Vincerx Pharma Inc reports results for the quarter ended in December - Earnings Summary

Vincerx Pharma

28/03/2023 21:57

* Vincerx Pharma Inc  VINC.OQ  reported a quarterly adjusted
loss
of 65 cents​​ per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 61 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vincerx Pharma Inc's reported EPS for the quarter was a
loss
of 65 cents​.
    * The mean earnings estimate of analysts had fallen by
about 29.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vincerx Pharma Inc shares had fallen by 7.8% this quarter.
    * The company reported a quarterly loss of $13.64 million.
    * Wall Street's median 12-month price target for Vincerx
Pharma
Inc is $7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 08:57 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.61          -0.65          Missed
 Sep. 30 2022      -0.55          -0.80          Missed
 Jun. 30 2022      -0.79          -0.88          Missed
 Mar. 31 2022      -0.76          -0.79          Missed